These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1778191)

  • 21. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB
    Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
    Lai C; Onnis E; Pirisi R; Orani E; Delogu G; Cherchi A
    Drugs Exp Clin Res; 1988; 14(11):699-705. PubMed ID: 3073077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
    Foale RA; Vandenburg MJ
    Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the efficacy of verapamil and diltiazem in stable exercise angina. A double-blind and crossover study].
    Belin A; Grieu P; Mabire JP; Kleszcz A; Sesboué B; Breut C; Scanu P; Albessard F; Grollier G; Potier JC
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):393-8. PubMed ID: 2108634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
    Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
    Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
    Schwartz JB; Jackson G; Kates RE; Harrison DC
    Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS; Lahiri A; Raftery EB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in response to single dose and steady-state therapy with verapamil in stable angina.
    Vazquez de Prada JA; Zueco J; Ruano J; Martin-Duran R; Sanjose JM; Colman T; Pajaron A
    Int J Cardiol; 1991 Sep; 32(3):339-45. PubMed ID: 1791086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?
    Romano M; Di Maro T; Carella G; Cotecchia MR; Caiazzo MR; de Arcangelis E; Chiariello M; Condorelli M
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):468-70. PubMed ID: 3198303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
    Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris.
    Foale RA
    Eur Heart J; 1993 Oct; 14(10):1369-74. PubMed ID: 8262084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-anginal effect of Tenormin (atenolol).
    Antalóczy Z; Kékes E
    Ther Hung; 1992; 40(2):58-63. PubMed ID: 1462277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
    Sandberg M; Foale RA
    Drugs; 1988; 35 Suppl 4():51-5. PubMed ID: 3132360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
    Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
    Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.